Results 151 to 160 of about 598,834 (266)
Review: acellular vaccines prevent pertussis as effectively as whole-cell vaccines with fewer adverse events [PDF]
Jim Buttery
openalex +1 more source
ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis
ABSTRACT Objective This phase 3b, open‐label, randomized ADAPT NXT study investigated the efficacy, safety, and tolerability of efgartigimod administered in either a fixed cycles dosing regimen (3 cycles of 4 once‐weekly infusions, with 4 weeks between cycles) or a cycle followed by every‐other‐week (Q2W) dosing.
Ali A. Habib+16 more
wiley +1 more source
Turning information into knowledge to prevent health care–associated infections and other adverse events: The electronic ICP as an agent of change [PDF]
Russell N. Olmsted
openalex +1 more source
ABSTRACT This study assessed whether continued treatment with anti‐CGRP monoclonal antibodies (mAbs) is driven more by reductions in monthly migraine days (MMDs) or patients' global impression of change (PGIC), a patient‐reported outcome. Among 169 patients treated with anti‐CGRP mAbs, 21.3% discontinued due to ineffectiveness. PGIC responders (≥ 5) at
Marina Romozzi+4 more
wiley +1 more source
Objective This work aimed to evaluate the pharmacokinetics, efficacy, and safety of upadacitinib, an oral selective JAK inhibitor, in pediatric patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods In an open‐label, phase 1 study (SELECT‐YOUTH), enrolled patients, aged 2 to <18 years with pcJIA, received body weight–based ...
Hermine I. Brunner+12 more
wiley +1 more source
Mining and analysis of dizziness adverse event signals in postoperative analgesia patients based on the FDA adverse event reporting system database. [PDF]
Zhou F, He H, Zhang Z, Gao J.
europepmc +1 more source
P02.319 Antipsychotic treatment, adverse events and health-related quality of life [PDF]
X Badia+5 more
openalex +1 more source
Objective The main objective of this study is to examine the safety of oral acetaminophen at its therapeutic dose in adults aged ≥65 years. Methods This population‐based cohort study used the Clinical Practice Research Datalink‐Gold data. Participants were aged ≥65 years registered with a UK general practice for at least 12 months between 1998 and 2018.
Jaspreet Kaur+5 more
wiley +1 more source
Intravascular ultrasound predictors of major adverse cardiac events in patients with unstable angina
Mariann Gyöngyösi+6 more
openalex +1 more source